455 related articles for article (PubMed ID: 28240179)
1. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
[TBL] [Abstract][Full Text] [Related]
2. Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.
Ji T; Zhao Y; Ding Y; Nie G
Adv Mater; 2013 Jul; 25(26):3508-25. PubMed ID: 23703805
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
4. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
5. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy.
Zandieh MA; Farahani MH; Daryab M; Motahari A; Gholami S; Salmani F; Karimi F; Samaei SS; Rezaee A; Rahmanian P; Khorrami R; Salimimoghadam S; Nabavi N; Zou R; Sethi G; Rashidi M; Hushmandi K
Biomed Pharmacother; 2023 Oct; 166():115283. PubMed ID: 37567073
[TBL] [Abstract][Full Text] [Related]
7. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
[TBL] [Abstract][Full Text] [Related]
8. Rationally designed DNA-based nanocarriers.
Jiang Q; Zhao S; Liu J; Song L; Wang ZG; Ding B
Adv Drug Deliv Rev; 2019 Jul; 147():2-21. PubMed ID: 30769047
[TBL] [Abstract][Full Text] [Related]
9. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
Dutta B; Barick KC; Hassan PA
Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
[TBL] [Abstract][Full Text] [Related]
12. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
Chen X; Lei S; Lin J; Huang P
Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
[TBL] [Abstract][Full Text] [Related]
13. Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.
Gao W; Meng T; Shi N; Zhuang H; Yang Z; Qi X
Adv Healthc Mater; 2015 Apr; 4(5):748-59. PubMed ID: 25522298
[TBL] [Abstract][Full Text] [Related]
14. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
Yao Q; Kou L; Tu Y; Zhu L
Trends Pharmacol Sci; 2018 Aug; 39(8):766-781. PubMed ID: 30032745
[TBL] [Abstract][Full Text] [Related]
15. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
16. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics.
Hatakeyama H
Chem Pharm Bull (Tokyo); 2017; 65(7):612-617. PubMed ID: 28674332
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
19. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.
Naz S; Shahzad H; Ali A; Zia M
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):899-916. PubMed ID: 28914553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
